Raymond James Upgrades Tectonic Therapeutic to Strong Buy, Raises Price Target to $81
Benzinga Newsdesk 5 months ago
NewsUpgradesPrice TargetAnalyst Ratings
Raymond James analyst Michael Freeman upgrades Tectonic Therapeutic (NASDAQ:TECX) from Outperform to Strong Buy and raises the price target from $76 to $81.
Raymond James analyst Michael Freeman upgrades Tectonic Therapeutic (NASDAQ:TECX) from Outperform to Strong Buy and raises the price target from $76 to $81.